Abstract:Jingyuan Zhang 1 Carolina Oi Lam Ung Anita Katharina Wagner Xiaodong Guan Luwen Shi 1Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, People’s Republic of China; 2State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, People’s Republic of China; 3Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA; 4International Research Center for Medicinal Administration, Peking University, Beijing, People’s Republic of China Purpose: This study aims to illustrate the prevalence and patterns of medication use among pregnant women in mainland China. Patients and methods: Hospital and drugstore service data for a nationally representative sample of basic medical insurance (BMI) beneficiaries in 2015 were obtained from the China Health Insurance Association (CHIRA) database. A total of 7946 women who had singleton deliveries in 2015, aged between 12 and 54, and whose records in the CHIRA database covered at least one trimester were included in this study. We conducted descriptive analyses of sample characteristics, medication use prevalence, and number and types of medications used. Results: We found that 11.7% of women used at least one medication during the course of pregnancy (median number of medications used = 6.7). Medication use was more common among those who were older, residing in Eastern China, or employed. Most commonly used medication groups by the Anatomical Therapeutic Chemical Classification System were B (Blood and blood forming organs, 49.3%), A (Alimentary tract and metabolism, 48.1%), G (Genito urinary system and sex hormones, 38.1%) and J (Antiinfectives for systemic use, 31.6%). Intravenous solutions, vitamins and minerals, progestogens, and beta-lactam antibacterials were the most frequently usedmedications from each of these four ATC groups, respectively. Moreover, 7.1% used at least one medication contraindicated in pregnancy. Conclusion: This study showed that around one in 10 women used medication during pregnancy in mainland China and found possible cases of inappropriate or unsafe medication use.

Analysis of Medicinal Substances and Cut Crude Drugs with Forbidding,Contraindication or Caution for Pregnancy in Chinese Pharmacopoeia(2005)

Chinese Herbal Medicine for Induced Abortion in Early Pregnancy (before 14 Weeks’ Gestation)

Pregnancy Outcomes, Embryonic and Fetal Development in Maternal Exposure to Chinese Medicines

Reference guides for the safe use of drugs during pregnancy: a systematic review and comparative analysis

Traditional Chinese Medicine and Traditional Indonesian Medicine: A Comparative Review of Herbal Medicines Restricted in Pregnancy

Safety of Medication Use During Pregnancy in Mainland China: Based on a National Health Insurance Database in 2015

[Residual status, toxicity, and analytical method of banned pesticides in traditional Chinese medicines].

Chemical profile and miscarriage prevention evaluation of Jiao-Ai Decoction, a classical traditional Chinese formula

Comparison on perinatal medicine between the results of evidence based medicine and current practice in China

Clep_a_230589 1057..1065

Safety evaluation of commonly used Chinese herbal medicines during pregnancy in mice.

A Review and Expectation of the Specification of Major Function Indicated of Chinese Patent Medicine in the Chinese Pharmacopoeia

Medication Use During Pregnancy in Mainland China: A Cross-Sectional Analysis of a National Health Insurance Database

'Risk-benefit' assessment for comprehensive safety evaluation of Chinese patent medicines containing four common toxic ingredients: an analysis of clinical risk factors

Safety of Chinese herbal medicines during pregnancy.

[Summary of Revised Contents of Medical Standards of Preparation Recorded in Chinese Pharmacopeia (I Division, 2010 Edition)].

Analysis of Outpatient Chinese Traditional Patent Medicine Prescriptions During the Third Quarter of 2008 in Our Hospital

Comparative efficacy and safety of Chinese patent medicines of iron deficiency anemia during pregnancy: A network meta-analysis

Survey and Analysis of Chinese Traditional Medicine Prescriptions in 2006 in Our Hospital

Tocolysis effects of traditional Chinese medicine and their effective components

Analysis of 136 ADRs Induced by Chinese Patent Medicine